Studies with quinidine and digoxin on the cardiac vulnerable period.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D004077:Digoxin / Q000627:therapeutic use*; D004285:Dogs; D004554:Electric Countershock; D004558:Electric Stimulation; D004562:Electrocardiography; D004594:Electrophysiology; D006327:Heart Block / Q000139:chemically induced; D006329:Heart Conduction System / Q000187:drug effects; D011802:Quinidine / Q000627:therapeutic use*; D013610:Tachycardia / Q000517:prevention & control*; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D004077:Digoxin; D011802:Quinidine